


Home Remedies
Topicals
Anti-Fungal Liquids
Lasers
Surgery
81% Efficacy with Onychomycosis and severe fungal nail
Uses dual-wavelength light to penetrate deep below the nail plate
Zero patient downtime, Zero pain during or after the treatment
Only 5 minutes of provider time per treatment
Treatment time of less than 3 minutes.
Can be delivered by DPMs, MDs, PAs, NPs, and MAs
Safe, clean, and requires no annual maintenance
No side effects, no liver risk, no systemic exposure
More referrals from dermatologists, PCPs, and other podiatrists
Average profit of $1,300 per patient vs traditional therapy
BeforeAfter
BeforeAfter
BeforeAfter
ToeFX is already in over 500 clinics around the world.

Step 1: Get the Success Guide which includes Case Studies, Clinical Trials, our Revenue Report, Practice Profit Predictability Chart, and Practice Webinar.
Step 2: Book a free call with an expert on our team to walk through the Success Guide and exactly what ToeFX can do for your practice.
Step 3: Choose a payment plan that works for you.

ToeFX Information Packet
ToeFX Clinical Studies
ToeFX Revenue Report
ToeFX Case Studies
ToeFX Success Webinar
Free ToeFX Success Call With Our Team


ToeFX's patented dual-wavelength technology uses a proprietary photoactivation formula combined with targeted light energy to treat moderate-to-severe onychomycosis. Providers report consistent clearance in patients who failed topicals, lasers, and orals ... including cases that would have been excluded from standard clinical studies. No longer do we need to rely on painful, systemic, or destructive methods to clear fungal nail infections. The game has changed.
Effective for moderate and severe onychomycosis
Effective for recalcitrant and chronic infections
Effective for thick dystrophic nails and dermatophytomas
Effective for patients who failed topicals, lasers, or orals
FDA Cleared
Flexible financing options available... speak with our team
Marketing collaboration... get our proven patient recruitment strategies
Section 179 tax write-off available
81% efficacy for cases other modalities miss
No side effects, no patient downtime
Ends the patient frustration loop
Increases referrals from dermatologists and PCPs
Over 60,000 treatments delivered globally
Over 575 practices succeeding with ToeFX worldwide
ToeFX has demonstrated 73% efficacy for moderate-to-severe onychomycosis ... including cases that would have been excluded from standard clinical studies due to infection severity. Upon request, we can share the full data set and study.
It really depends on what your practice goals are, however we see the following primary benefits: Increased profit per patient, Enhanced provider efficiency (2-3 min treatment times), New patient flow from referring providers, Brand enhancement
Your device can be at your door within 30 days of starting! Training/certification can be delivered virtually by a member of our team in less than an hour and all providers can be certified to treat.

© Copyright 2026 ToeFX | Privacy | Terms and Conditions